Hidenori Ojima
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 20
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 29
- Cancer Research top 1%
- Surgery top 0.5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 49
-
- Gallbladder and Bile Duct Disorders 23
-
- Liver Disease Diagnosis and Treatment 17
-
- Epigenetics and DNA Methylation 16
- RNA modifications and cancer 13
- Cancer-related gene regulation 10
- Co-authors
- Tomoo KosugeTatsuhiro ShibataKazuaki ShimadaNobuyoshi HiraokaYae KanaiSetsuo HirohashiYoshihiro SakamotoAkiko Kokubu
- Cited by
- HepatologyOncologyCancer Research
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Hidenori Ojima
120 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Hepatology 936
- Oncology 2.6k
- Cancer Research 1.2k
- Surgery 2.9k
- Pulmonary and Respiratory Medicine 1.5k
Countries citing papers authored by Hidenori Ojima
This map shows the geographic impact of Hidenori Ojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidenori Ojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidenori Ojima more than expected).
Fields of papers citing papers by Hidenori Ojima
This network shows the impact of papers produced by Hidenori Ojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidenori Ojima. The network helps show where Hidenori Ojima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hidenori Ojima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2019 | 4 | |
| 6 | 2019 | 22 | |
| 7 | 2018 | 27 | |
| 8 | 2018 | 17 | |
| 9 | 2017 | 1 | |
| 10 | 2015 | 77 | |
| 11 | 2015 | 25 | |
| 12 | 2014 | 5 | |
| 13 | 2013 | 69 | |
| 14 | 2012 | 0 | |
| 15 | 2012 | 44 | |
| 16 | 2010 | 138 | |
| 17 | 2008 | 31 | |
| 18 | 2008 | 26 | |
| 19 | 2006 | 14 | |
| 20 | 2005 | 57 |
About Hidenori Ojima
Hidenori Ojima is a scholar working on Hepatology, Oncology and Surgery, having authored 124 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (49 papers), Pancreatic and Hepatic Oncology Research (29 papers), Gallbladder and Bile Duct Disorders (23 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Liver Disease Diagnosis and Treatment (17 papers), Epigenetics and DNA Methylation (16 papers), RNA modifications and cancer (13 papers) and Cancer-related gene regulation (10 papers). The work is most often cited by research in Hepatology (936 citations), Oncology (2.6k citations) and Cancer Research (1.2k citations). Hidenori Ojima has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Tomoo Kosuge, Tatsuhiro Shibata, Kazuaki Shimada, Nobuyoshi Hiraoka, Yae Kanai, Setsuo Hirohashi, Yoshihiro Sakamoto, Akiko Kokubu, Tsuyoshi Sano and Takuji Okusaka. Their work appears in journals such as Nature Genetics, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.